EA200601392A1 - Способы и композиции для лечения липодистрофии - Google Patents
Способы и композиции для лечения липодистрофииInfo
- Publication number
- EA200601392A1 EA200601392A1 EA200601392A EA200601392A EA200601392A1 EA 200601392 A1 EA200601392 A1 EA 200601392A1 EA 200601392 A EA200601392 A EA 200601392A EA 200601392 A EA200601392 A EA 200601392A EA 200601392 A1 EA200601392 A1 EA 200601392A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lipodystrophy
- methods
- treatment
- compositions
- hiv
- Prior art date
Links
- 206010049287 Lipodystrophy acquired Diseases 0.000 title abstract 4
- 208000006132 lipodystrophy Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к способам и композициям для лечения липодистрофии. Способы предусматривают лечение липодистрофии как у ВИЧ, так и у не-ВИЧ пациентов. Более конкретно, способы относятся к комбинированной терапии, в которой используют гормон роста и статины для осуществления лечения липодистрофии.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54020404P | 2004-01-29 | 2004-01-29 | |
| US54336604P | 2004-02-10 | 2004-02-10 | |
| PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200601392A1 true EA200601392A1 (ru) | 2006-12-29 |
Family
ID=34841102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200601392A EA200601392A1 (ru) | 2004-01-29 | 2005-01-26 | Способы и композиции для лечения липодистрофии |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1722778A1 (ru) |
| JP (1) | JP2007519669A (ru) |
| KR (1) | KR20060127977A (ru) |
| AU (1) | AU2005210093A1 (ru) |
| BR (1) | BRPI0507302A (ru) |
| CA (1) | CA2552404A1 (ru) |
| EA (1) | EA200601392A1 (ru) |
| IL (1) | IL176762A0 (ru) |
| NO (1) | NO20063279L (ru) |
| WO (1) | WO2005074916A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
| CN103372215B (zh) * | 2008-01-03 | 2016-03-09 | 艾克斯-马赛大学 | 抗hiv治疗期间使用的组合物和方法 |
| US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
| JP6712230B2 (ja) * | 2014-03-11 | 2020-06-17 | ノバルティス アーゲー | リポジストロフィーおよびインスリン産生の欠損またはインスリンシグナル伝達の欠損と関連する代謝性障害を処置する方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0507302A (pt) | 2007-06-26 |
| NO20063279L (no) | 2006-09-19 |
| JP2007519669A (ja) | 2007-07-19 |
| WO2005074916A1 (en) | 2005-08-18 |
| AU2005210093A1 (en) | 2005-08-18 |
| KR20060127977A (ko) | 2006-12-13 |
| EP1722778A1 (en) | 2006-11-22 |
| CA2552404A1 (en) | 2005-08-18 |
| IL176762A0 (en) | 2006-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
| EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
| MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
| EA200700225A1 (ru) | Аналоги тетрапептида | |
| EA200870569A1 (ru) | Соединения и способы модуляции fxr | |
| EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
| EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| EA200901490A1 (ru) | Химические соединения | |
| MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| MX346450B (es) | Composiciones y métodos para el tratamiento de la enfermedad celíaca. | |
| BRPI0508390B8 (pt) | uso de um anticorpo antagonista anti-ngf, bem como kit e composição farmacêutica para tratamento de dor de câncer de osso | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA201290356A1 (ru) | Композиции для лечения тошноты и рвоты центрального происхождения | |
| ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
| EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
| EA201400423A1 (ru) | Фармацевтические препараты и их применение при лечении половой дисфункции у женщин | |
| ATE555108T1 (de) | Polyamide zur behandlung des menschlichen papilloma-virus | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения |